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1002-77 Regional Desensitization of β-Adrenergic Receptor 
Signaling in Swine With Chronic Hibernating 
Myocardium
Vijay S. Iyer, John M. Canty, Jr., University at Buffalo, Buffalo, NY, VA Medical Center, 
Buffalo, NY
Background: Contractile reserve to submaximal β-adrenergic stimulation is attenuated
in patients and swine with hibernating myocardium and the blunted contractile response
is not related to metabolic evidence of ischemia. This study tested the hypothesis that
there is an attenuation of β-adrenergic signaling arising as a regional adaptive response
in hibernating myocardium.
Methods & Results – Pigs (n=8) with chronic hibernating myocardium were studied 3-
months after instrumentation with a chronic LAD stenosis. At the time of study, resting
subendocardial flow (LAD 0.7±0.2 vs. 1.2±0.1 ml/min/g in normal, p<0.05) and regional
LAD wall thickening (LAD 1.9±0.5 vs. 5.5±0.4 mm in normal, p<0.05) were reduced in the
absence of infarction. We assessed regional β-adrenergic responsiveness in suben-
docardial membrane fractions from hibernating LAD vs. normally perfused remote
regions. Total β-receptor density was unchanged in hibernating myocardium (LAD: 97
±13 vs.103 ± 8 fmol/mg in Normal) but there was shift from a 2-state (high and low-affin-
ity) model (Ki: 775 ± 288 pM and 0.9 ± 0.6µM) to a low-affinity β-adrenergic receptor
state in hibernating myocardium (Ki: 0.5 ± 0.4µM). The proportion of β1 receptors was
unchanged (LAD: 79 ± 1 vs. 75 ±3 % in Normal). Western analysis demonstrated normal
levels of adenylyl cyclase and no alterations in G-protein receptor kinase 2 and 5. Inter-
estingly, there were reciprocal changes in Gα-proteins with an increase in Gαi and reduc-
tion in Gαs in hibernating myocardium. These changes were associated with reduced
isoproterenol and GppNHp stimulated cAMP accumulation while basal and forskolin
stimulated responses were unchanged.
Conclusions – These data support the notion that there is a regional attenuation of β-
receptor adenylyl cyclase coupling in hibernating myocardium that may lead to attenu-
ated contractile reserve when myocardial viability is present. The observations support
the notion that intrinsic adaptations in hibernating myocardium serve to protect the
regional circulation from a myocardial supply/demand imbalance when external determi-
nants of myocardial workload increase during sympathetic activation.
1002-78 The Critical Role of Thrombospondin (TSP)-1 in Limiting 
Expansion of Fibrosis in Healing Myocardial Infarcts: 
Studies in Dogs and TSP-1 -/- Mice
Guofeng Ren, Oliver Dewald, Sophia Tincey, Anna Koerting, Pawel Zymek, Lloyd 
Michael, Mark Entman, Jack Lawler, Nikolaos G. Frangogiannis, Baylor College of 
Medicine, Houston, TX
Background: Healing of a myocardial infarct depends on suppression of the inflammatory
response after scar formation and prevention of its expansion to normal areas. We
observed that expression of Thrombospondin (TSP)-1, a potent inhibitor of angiogenesis
and activator of TGF-β, is localized in the border zone of healing canine infarcts and
hypothesized that it may suppress the inflammatory response, inhibiting local angiogene-
sis and limiting expansion of fibrotic tissue to the non-infarcted area.
Methods: A canine and a murine model of reperfused myocardial infarction were used.
Morphometric variables and gene expression were studied in wild type and TSP-1 -/-
mice using immunohistochemistry and RNAse protection assays. In vitro experiments
examined the effects of TSP-1 stimulation on canine endothelial cells.
Results: TSP-1 mRNA was induced in canine infarcts after 1 h of ischemia and 3-7 days
of reperfusion. TSP-1 protein was localized in the extracellular matrix and microvascular
endothelium of the ischemic border zone after 5-28 days of reperfusion. Isolated canine
venous endothelial cells showed constitutive expression of TSP-1 mRNA, which was
downregulated by TNF-α and IL-1β but was markedly induced by TGF-β and bFGF. TSP-
1- stimulated canine endothelial cells demonstrated a significant downregulation of MT1-
MMP, but not TIMP-1 or TIMP-2 mRNA expression. Murine infarcts also exhibited marked
TSP-1 deposition in the border zone. TSP-1 -/- mice had significantly higher collagen
α1(I) mRNA synthesis and increased macrophage and myofibroblast accumulation in the
infarct (p<0.05), with extensive infiltration of the neighboring non-infarcted area, when
compared with their wildtype littermates (p<0.01). Furthermore, expression of the pro-
inflammatory cytokines IL-1β, IL-6 and TNF-α was higher in infarcted TSP-1 knockout
animals, possibly because of impaired TGF-β activation.
Conclusions: Our findings suggest that TSP-1 expression in the border zone of healing
myocardial infarcts may act as a barrier, limiting expansion of the inflammatory process
to the non-infarcted myocardium and decreasing inappropriate fibrosis. These effects
may regulate post-infarction remodeling.
1002-79 The Peroxisome Proliferator Activated Receptor-α 
Activator, Fenofibrate, Improves Recovery of Left 
Ventricular Contractile Function After Ischemia and 
Reperfusion in Pigs
Ya Xu, Michael Gen, Li Lu, Clifford Greyson, Carlin S. Long, Gregory G. Schwartz, VA 
Medical Center and University of Colorado Health Sciences Center, Denver, CO
Peroxisome proliferator-activated receptor (PPAR)-α is a nuclear receptor involved in
substrate metabolism and inflammatory responses. The functional importance of PPAR-
α in myocardium is unknown. We determined if chronic treatment with the PPAR-α acti-
vator, fenofibrate (FENO), modifies the response to myocardial ischemia (ISC) and reper-
fusion (REP) in pigs. Methods: Fifteen pigs were treated with FENO 50 mg/kg/d orally
for 4 weeks; 15 untreated pigs served as controls (CON). Plasma FENO concentration
was similar to that achieved in clinical use. At 4 wks, both groups underwent 90 min low
flow regional myocardial ISC followed by 120 min REP, resulting in myocardial stunning.
Regional LV external work (sonomicrometry), blood flow, substrate uptake, and cytokine
mRNA expression (IL-1β, IL-6, IF-γ) were measured. Results: PPAR-α mRNA expres-
sion in myocardium was confirmed by ribonuclease protection assay, fulfilling a neces-
sary condition for the action of a PPAR-α activator. Prior to ISC, regional LV function and
substrate uptake did not differ between groups. During ISC, reductions in blood flow were
similar in both groups. During both ISC and REP, LV function was depressed in both
groups but better preserved in FENO than CON (p<.05, Table), without differences in
myocardial substrate uptake or cytokine mRNA expression. Conclusion: Chronic treat-
ment with FENO attenuates the severity of LV stunning in pigs. The mechanism of pro-
tection appears to be unrelated to substrate uptake or cytokine expression.
1002-80 Angiotensin II Inhibition of Vascular Matrix 
Metalloproteinases in Heart Failure Is Nitric Oxide-
Dependent
Mohamed A. Gaballa, Nicholle Johnson, Steven Goldman, Hoang Thai, University of 
Arizona Sarver Heart Center, Tucson, AZ, SAVAHCS, Tucson, AZ
Introduction: The role of angiotensin II (AngII) in promoting vascular remodeling is well
established. However, the mechanisms of AngII-mediated remodeling in ischemic heart
failure (IHF) are unclear. We hypothesized that AngII mediates vascular remodeling in
IHF by modulating the balance of matrix metalloproteinases (MMPs) and their tissue
inhibitors (TIMPs). Methods: Segments of rat aortic segments were treated ex vivo with
AngII (100 mM ) and AT1 receptor blocker, candesartan (100 mM) for 24 hrs. MMP/TIMP
activities were measured using gelatin zymography. In addition, aortic rings were treated
with a nitric oxide inhibitor, L-NAME (200 µM) to determine if AngII effects are nitric
oxide-dependent.Results: In both sham and IHF, AngII decreased MMP-2 and -9 activi-
ties compared to untreated controls. L-NAME reversed the effects of AngII on MMP-2
and -9 to 100% in sham and to 80% in IHF, compared to untreated controls. Similarly
candesartan reversed the effects of AngII on MMP-2 and -9 to 90% in sham and only to
5% in IHF compared untreated controls. Conclusion: AngII-mediated decrease in vas-
cular MMP activities is NO-dependent, while the effects of candesartan on MMP-2 and -9
activation is mainly due to AT1 receptor blockade. This study suggests that AngII modula-
tion of MMP-2 and -9 may be AT2 receptor mediated. 
1002-81 Age-Related Changes in Adaptation of the Heart to 
Ischemia-Reperfusion: A Possible Role for NADPH 
Oxidase-Induced Superoxide Production
Alexandra Oudot, Caroline Martin, David Busseuil, Pierre Sicard, Bertrand Collin, 
Catherine Vergely, Luc Demaison, Luc Rochette, LPPCE, Dijon, France, INRA, Dijon, 
France
Background: Aging is associated with an increase in myocardial susceptibility to
ischemia and a decrease in post-ischemic recovery. However, the mechanisms involved
regarding age-related changes are still not clear. The aim of our study was to examine
age-related differences in myocardial ischemia-reperfusion and to determine the possible
relationship between oxidative stress and age.
Methods: Isolated perfused hearts from young (2 months) (Y), adults (6 months) (A) and
old (21 months) (O) rats underwent 30 min of global total ischemia followed by 30 min of
reperfusion. The spin-probe CP-H (0.1 µM) was perfused in order to evaluate (in coro-
nary effluents) superoxide-associated oxidative stress during reperfusion using electron
spin resonance spectroscopy (ESR). Studies concerning vascular NADPH oxidase were
Regional LV ext work (fraction of baseline). Note: Baseline function did not differ 
between groups.
Group ISC REP
CON (n=15) 0.30±.03 0.14±.05
FENO (n=15) 0.42±.04 0.26±.05
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performed using CP-H associated with ESR, dihydroethidium (DHE) oxidative fluores-
cence and immunohistochemistry (gp91phox and p22phox).
Results: During the pre-ischemic period, an aged-related decrease in myocardial func-
tional parameters (coronary flow, left ventricular developed pressure, heart rate) was
observed. After ischemia, we noted a partial functional recovery which was higher in Y
hearts compared with A and O hearts (respectively 17.0±2.2, 5.0±2.8, 5.4±2.6 % of the
preischemic values). Our results showed a large release of oxidized CP-H (CP•) during
the first minutes of reperfusion which was increased with age (1,296±164 AU in Y hearts,
2,052±188 AU in A hearts, 2,425±405 AU in O hearts). The activity and expression of the
vascular NADPH oxidase increased with age according to the ESR approach (14±1 AU
in Y group, 20±3 AU in A group, 33±4 AU in O group), fluorescence microscopy (DHE)
and immunohistochemistry for gp91phox (0.7±0.1 AU in Y group, 1.5±0.1 AU in A group,
2.1±0.1 AU in O group) and p22 phox; NADPH oxidase involved in these changes being
localized in endothelial cells.
Conclusion: Our study suggests that myocardial function and adaptation to ischemia-
reperfusion decrease during aging and is related to an higher level of oxidative stress.
Endothelial NADPH oxidase appears to be an important contributor to the age-related
cardiovascular deterioration.
1002-82 Impact of Body Mass Index on Outcomes After Primary 
Angioplasty in Acute Myocardial Infarction: The Obesity 
Paradox
Eugenia Nikolsky, Roxana Mehran, Alexandra J. Lansky, Cindy L. Grines, David A. Cox, 
Eulogio Garcia, James E. Tcheng, John J. Griffin, Giulio Guagliumi, Thomas Stuckey, 
Mark Turco, David A. Cohen, Barry Rutherford, Gregg W. Stone, The Cardiovascular 
Research Foundation, New York, NY
Background The significance of body mass index (BMI) in pts with acute myocardial inf-
arction (AMI) undergoing primary percutaneous coronary intervention (PCI) is unknown.
Methods and Results. In the CADILLAC trial, 2035 pts undergoing primary PCI for AMI
were divided into 3 groups based on BMI: non-obese (<25), mildly obese (>25 to <30)
and very obese (>30 kg/m2). Non-obese pts were older, more frequently female, and had
higher rate of intervention on LAD, while very obese pts had higher prevalence of diabe-
tes and hyperlipidemia. Target vessel reference diameter was smaller in non-obese
(median 2.89 mm) compared to mildly obese (3.01 mm, P<0.0001) and very obese pts
(3.05mm, P<0.0001), while number of diseased vessels and ejection fraction did not dif-
fer among the groups. The rates of 1-year mortality and of disabling stroke were highest
in non-obese pts (Table). However, by multivariate analysis, non-obese pts were not at
increased risk of mortality compared with mildly obese (HR=0.68, 95% CI 0.35, 1.32) and
severely obese pts (HR=0.55, 95% CI 0.22, 1.34). Rather, predictors of 1-year mortality
included age (P=0.0002), LAD infarct vessel (P=0.002), and reduced ejection fraction
(P<0.0001). Conclusions. Compared to obese pts, the 1-year prognosis of pts with low-
normal BMI is significantly worse after primary PCI for AMI. This apparent “obesity para-
dox” may be explained by the fact that non-obese pts presenting with AMI are older and
more frequently have anterior infarction than their obese counterparts.
1002-83 Prognostic Indications of a Novel Biological Marker of 
Cardiac Ischemia in Patients Presenting With Chest 
Pain in an Emergency Setting
Guillaume Lefevre, Aigline Lefranc, Eric Garbarz, Eric Bouvard, Hanafi Graine, Frank 
Seghatol, Pierre Louis Michel, Jacqueline Capeau, Tenon Hospital, Paris, France
Background: Ischemia Modified Albumin (IMA™) measured by the Albumin Cobalt
Binding (ACB®) test (Ischemia Technologies, Denver, CO, USA) is a new quantitative
biomarker which measures cobalt binding capacity of albumin modified as a result of
myocardial ischemia. This study was conducted to investigate IMA in patients presenting
with chest pain and assess its relationship to cardiac outcome at 6 weeks.
Methods: 95 patients (60 + 17 yrs, 56 males) with chest pain at presentation were stud-
ied. Serum samples were collected and traditional cardiac necrosis markers (total CK
activity, CKMB, Troponin I (cTnI), Myoglobin) as well as IMA (measured on the KoneLab
20) were determined. Serum for IMA was separated and stored at –20°C prior to analy-
sis. Cut-off values for CK, CKMB, cTnI, Myoglobin and ACB were 180 U/L, 10 U/L, 0.25
µg/L, 110 µg/L and 85 U/mL, respectively.
Results: Time from chest pain onset to presentation was less than 1 hour in 8 patients
(8.5%), 1-2 hours in 15 patients (16%), 2-3 hours in 26 patients (27%), 3-6 hours in 13
patients (13.8%), 6-12 hours in 25 patients (26.5%), and >12 hours in 7 patients (7.2%).
Myoglobin was elevated in 17 patients (17.8 %), total CK in 24 patients (25.3 %) and cTnI
in 14 patients (14.7%) consistent with a high risk population arriving late with respect to
pain onset. IMA (100 + 10 U/mL) was elevated in 84 patients (88%). There was no corre-
lation between IMA and any necrosis marker. When considering adverse cardiac events
at 6 weeks (ischemic ECG changes, cTnI increase, MI, revascularisation and death due
to cardiac complication), presentation IMA sensitivity was 97.5% (95% CI: 86.8-99.6%),
specificity was 17.9% (95% CI: 8.9-30.4%) and NPV was 90.9% (95% CI: 74-100%). IMA
was significantly lower in 57 patients with no complications (95 + 11 U/mL) versus 12
patients with follow-up complications (103 + 7 U/mL), p < 0.05.
Conclusions: Our results show that IMA is a highly sensitive marker for coronary syn-
dromes even in patients with normal cardiac necrosis marker values, however, it is non-
specific. Negative predictive value is high for safe rule-out. IMA could be a useful tool for
predicting future cardiac complications in patients with chest pain in the emergency set-
ting.
1002-84 Eplerenone Normalizes Diastolic Relaxation and 
Extracellular Matrix Accumulation in Aged Rats With 
Myocardial Infarction
Serge Masson, Lidia Staszewsky, Giorgio Annoni, Eleonora Carlo, Beatrice Arosio, 
Monica Salio, Carmen Calabresi, Fabio Fiordaliso, Elena Martinoli, Antonio Bai, Amy E. 
Rudolph, Roberto Latini, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy, 
IRCCS Ospedale Maggiore, Milan, Italy
Background: The incidence and severity of CVdiseases increase rapidly with age.
Aldosterone blockers have shown benefits in patients with LV dysfunction after MI and in
HF. However, efficacy of these agents in experimental models of MI in aged animals has
not been explored. Methods: 16-month old rats were divided into controls (sham, n= 9),
MI (coronary artery ligation, n= 9) and MI with eplerenone in diet (MI + Eple, 120 mg/kg/
d, n= 9). Treatment started 18 days after surgery, until sacrifice 3 months later. LV func-
tion and dimensions were investigated by echocardiography and hemodynamics. Cardiac
fibrosis and the elastin-to-collagen ratio in thoracic aorta were evaluated by histology.
Results: Untreated MI rats had systolic impairment (LVEF: 58 ± 8 vs. 73 ± 2 % in con-
trols, p< 0.05) and clear evidence of diastolic dysfunction (increase of E wave decelera-
tion time DT, and decrease of E wave velocity from 73 ± 3 to 63 ± 5 cm/s (p< 0.05),
increase of isovolumic relaxation time from 22 ± 2 to 28 ± 3 ms). LV relaxation was
depressed in MI rats (-dP/dt: -33%). Cardiac interstitial fibrosis increased by 23%, while
aorta elastin-to-collagen ratio decreased by 40% (Figure). Eplerenone normalized
echocardiographic and hemodynamic parameters of diastolic relaxation, cardiac intersti-
tial fibrosis and elastin-to-collagen ratio in aorta (Figure). Conclusion: Eplerenone was
well tolerated by aged rats. Aldosterone blockade normalized diastolic relaxation after MI,
and blunted cardiac and aortic collagen accumulation.
1002-97 Effects of Preinfarction Angina Pectoris on Left 
Ventricular Function in Diabetic Patients With a First ST-
Elevation Myocardial Infarction Treated With Primary 
Percutaneous Coronary Intervention
Calveri Giuseppe, Dajelli Ermolli Carlo, Rogiani Silvia, Saporiti Lucia, Bertelli Ylenia, 
Caico Salvatore, Uriarte-Salerno Jorge Antonio, Ospedale di Circolo - Università 
dell'Insubria, Varese, Italy
INTRODUCTION: In patients with acute myocardial infarction undergoing primary percu-
taneous coronary intervention (PCI) the presence of preinfarction angina (PA), clinical
sign of the phenomenon known as “ischemic preconditioning”, has been shown to exert
in the ischemic myocardium a protective effect on left ventricular function. Whether the
same occurs in diabetic patients (DP) remains unknown.
METHODS: We studied 183 nondiabetic patients (NDP) (mean age 67 years, 29%
female) and 153 DP (age 69 years, 39% female), hospitalized in our Coronary Care Unit
for a first ST-segment elevation acute myocardial infarction and treated with successful
PCI on the culprit lesion (TIMI 3 flow restored). 2D-echocardiographic left ventricular
ejection function (LVEF) on admission was compared with LVEF at hospital discharge.
Time from angina pectoris to balloon (TAB), ST-segment resolution >50%, T-wave inver-
sion after PCI, CK-MB peak and in-hospital events were compared in both groups.
RESULTS: In the study population, PA was found in 137 subjects (mean age 67 years,
35% female, 62 DP). When PA was present, creatine kinase peak was sensibly lower in
NDP (986 vs 1659 UI/L p=0.025) with earlier ST-segment resolution (9.5 vs 18.3 hours
p=0.009) and T-wave inversion (90 minutes after PCI: 62.0% vs 37.3% p=0.007), while
no differences were instead observed in diabetic ones (all p=ns). Furthermore, in DP an
inverse correlation was evidenced between LVEF after PCI and TAB (R=-0.47 p=0.019)
but not in NDP with PA (R=-0.23 p=ns). At discharge, LVEF improvement was superior in
NDP (+13.6% vs +8.9% p=ns) especially when PA was present (+21.6% vs 8.1%
p=0.041), while in DP with PA no differences were evidenced (+8.5% vs +9.3% p=ns).
Similarly, PA was associated to reduced incidence of left ventricular expansion (4.0% vs
14.9% p=0.049) and cardiac failure (12.0% vs 26.9% p=0.035) only in NDP.
CONCLUSIONS: Our results suggest that in diabetic patients with acute myocardial inf-
arction treated with percutaneous coronary intervention, PA do not induce protective
effects in the ischemic myocardium, probably due to loss of myocyte preconditioning
which reduces tolerance to ischemia and worsens left ventricular function.
Endpoint, % Body mass index (kg/m2)  P-value*
 <25.0
 N=552
>25.0 to<30.0
 N=915
>30.0
 N=568
Death  7.5  3.6 1.8  <0.0001
Any MI  1.9  2.4 2.7  0.68
Ischemic TVR  11.4  13.8 14.5  0.27
Disabling stroke  1.4 0.1 0.4  0.006
Any MACE  18.9 17.1 17.0  0.65
*By analysis of variance. TVR=target vessel revascularization. MACE=major adverse 
cardiac events
